We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWSSW
10301
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
-92
Closed -$2
AONC
10302
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
-3,351
Closed -$18.4K
AONCW
10303
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-10
Closed -$3
TWLVW
10304
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
-1,818
Closed -$156
VTRU
10305
DELISTED
Vitru Limited Common Shares
VTRU
-700
Closed -$10.5K
PLTNR
10306
DELISTED
Plutonian Acquisition Corp. Rights
PLTNR
-13
Closed -$2
OAIB
10307
DELISTED
Teucrium AiLA Long/Short Base Metals Strategy ETF
OAIB
-41
Closed -$1.02K
HLTH
10308
DELISTED
Cue Health Inc. Common Stock
HLTH
-70,857
Closed -$13.4K
MTAL.WS
10309
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
-4,326
Closed -$8.82K
FUSN
10310
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-79,609
Closed -$1.7M
GRTX
10311
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-293,502
Closed -$41.1K
UGIC
10312
DELISTED
UGI Corporation
UGIC
-115
Closed -$6.69K
SWAV
10313
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-47,138
Closed -$15.3M
CLVT.PRA
10314
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
-4
Closed -$119
ERF
10315
DELISTED
Enerplus Corporation
ERF
-1,259,190
Closed -$24.8M
BREZR
10316
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
-6,394
Closed -$1.22K
QDROW
10317
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
-7,539
Closed -$264
SCX
10318
DELISTED
The L.S. Starrett Company
SCX
-2,050
Closed -$32.6K
ACBA
10319
DELISTED
Ace Global Business Acquisition Ltd
ACBA
-52
Closed -$628
PUCKW
10320
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
-46,699
Closed -$420
KOIN
10321
DELISTED
Capital Link Global Fintech Leaders ETF
KOIN
-147
Closed -$4.88K
ISUN
10322
DELISTED
iSun, Inc. Common Stock
ISUN
-17,798
Closed -$4.45K
AMJ
10323
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-5,621
Closed -$160K
ALPN
10324
DELISTED
Alpine Immune Sciences Inc
ALPN
-153,473
Closed -$6.08M
FHLT
10325
DELISTED
Future Health ESG Corp. Common stock
FHLT
-1
Closed -$11

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.